Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuno Gil

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Lung Cancer (Amsterdam, Netherlands)|February 14, 2026
Altered bacteriome and mycobiome in small cell lung cancer: insights from microbial profilingInes Rolim, Antonio Lopez-Beltran, Marcos Pantarotto, et al.
Cureus|August 15, 2022
The Meaning of Lymphadenopathies During Adjuvant Durvalumab After Chemoradiotherapy for Lung Cancer: Thinking Beyond Disease ProgressionMarcos Pantarotto, Rita Barata, Ricardo Coelho, et al.
Frontiers in Medicine|March 18, 2020
Pulmonary Administration: Strengthening the Value of Therapeutic ProximityMafalda A Videira, Jordi Llop, Carolina Sousa, et al.
Cureus|February 23, 2023
Correction: The Meaning of Lymphadenopathies During Adjuvant Durvalumab After Chemoradiotherapy for Lung Cancer: Thinking Beyond Disease ProgressionMarcos Pantarotto, Rita Barata, Ricardo Coelho, et al.
Antioxidants (Basel, Switzerland)|July 1, 2020
Impact of the APE1 Redox Function Inhibitor E3330 in Non-small Cell Lung Cancer Cells Exposed to Cisplatin: Increased Cytotoxicity and Impairment of Cell Migration and InvasionRita Manguinhas, Ana S Fernandes, João G Costa, et al.
Translational Lung Cancer Research|July 23, 2021
A narrative review of the migration and invasion features of non-small cell lung cancer cells upon xenobiotic exposure: insights from <i>in vitro</i> studiesCatarina Albuquerque, Rita Manguinhas, João G Costa, et al.
Molecular Nutrition & Food Research|June 25, 2025
Protective Role of the Natural Antioxidant Astaxanthin in Both Human Bronchial Epithelial Cells (BEAS-2B) and Non-Small Cell Lung Cancer Cells (H1975) Exposed to Cadmium: Impact on the Generation of Reactive Oxygen Species and Cancer Cell MigrationDaniel C Carreira, Rita Manguinhas, Rita B Soares, et al.
Biochemical Pharmacology|July 14, 2024
Impact of the redox-active MnTnHex-2-PyP<sup>5+</sup> and cisplatin on the metabolome of non-small cell lung cancer cellsRita B Soares, Joana Pinto, Filipa Amaro, et al.
Cancers|August 12, 2023
The Redox-Active Manganese(III) Porphyrin, MnTnBuOE-2-PyP<sup>5+</sup>, Impairs the Migration and Invasion of Non-Small Cell Lung Cancer Cells, Either Alone or Combined with CisplatinRita B Soares, Rita Manguinhas, João G Costa, et al.
Antioxidants (Basel, Switzerland)|November 11, 2022
MnTnHex-2-PyP<sup>5+</sup> Displays Anticancer Properties and Enhances Cisplatin Effects in Non-Small Cell Lung Cancer CellsRita B Soares, Rita Manguinhas, João G Costa, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Lung Cancer (Amsterdam, Netherlands)|February 14, 2026
Altered bacteriome and mycobiome in small cell lung cancer: insights from microbial profilingInes Rolim, Antonio Lopez-Beltran, Marcos Pantarotto, et al.
Cureus|August 15, 2022
The Meaning of Lymphadenopathies During Adjuvant Durvalumab After Chemoradiotherapy for Lung Cancer: Thinking Beyond Disease ProgressionMarcos Pantarotto, Rita Barata, Ricardo Coelho, et al.
Frontiers in Medicine|March 18, 2020
Pulmonary Administration: Strengthening the Value of Therapeutic ProximityMafalda A Videira, Jordi Llop, Carolina Sousa, et al.
Cureus|February 23, 2023
Correction: The Meaning of Lymphadenopathies During Adjuvant Durvalumab After Chemoradiotherapy for Lung Cancer: Thinking Beyond Disease ProgressionMarcos Pantarotto, Rita Barata, Ricardo Coelho, et al.
Antioxidants (Basel, Switzerland)|July 1, 2020
Impact of the APE1 Redox Function Inhibitor E3330 in Non-small Cell Lung Cancer Cells Exposed to Cisplatin: Increased Cytotoxicity and Impairment of Cell Migration and InvasionRita Manguinhas, Ana S Fernandes, João G Costa, et al.
Translational Lung Cancer Research|July 23, 2021
A narrative review of the migration and invasion features of non-small cell lung cancer cells upon xenobiotic exposure: insights from <i>in vitro</i> studiesCatarina Albuquerque, Rita Manguinhas, João G Costa, et al.
Molecular Nutrition & Food Research|June 25, 2025
Protective Role of the Natural Antioxidant Astaxanthin in Both Human Bronchial Epithelial Cells (BEAS-2B) and Non-Small Cell Lung Cancer Cells (H1975) Exposed to Cadmium: Impact on the Generation of Reactive Oxygen Species and Cancer Cell MigrationDaniel C Carreira, Rita Manguinhas, Rita B Soares, et al.
Biochemical Pharmacology|July 14, 2024
Impact of the redox-active MnTnHex-2-PyP<sup>5+</sup> and cisplatin on the metabolome of non-small cell lung cancer cellsRita B Soares, Joana Pinto, Filipa Amaro, et al.
Cancers|August 12, 2023
The Redox-Active Manganese(III) Porphyrin, MnTnBuOE-2-PyP<sup>5+</sup>, Impairs the Migration and Invasion of Non-Small Cell Lung Cancer Cells, Either Alone or Combined with CisplatinRita B Soares, Rita Manguinhas, João G Costa, et al.
Antioxidants (Basel, Switzerland)|November 11, 2022
MnTnHex-2-PyP<sup>5+</sup> Displays Anticancer Properties and Enhances Cisplatin Effects in Non-Small Cell Lung Cancer CellsRita B Soares, Rita Manguinhas, João G Costa, et al.
Pageof 2